OR WAIT null SECS
Seattle
Washington
Timothy S. Dutill is the process development specialist II at the Infections Disease Research Institute
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).